- Open
- 24.50
- High
- 25.59
- Low
- 24.40
- Close
- 24.76
- Change
- -0.65 (-2.57%)
- Volume
- 157,352
⌘K
| 27 Apr 2026 | 07:00:10 | Board Changes |
| 24 Apr 2026 | 16:43:41 | Posting of Annual Report & Notice of AGM |
| 13 Apr 2026 | 07:00:03 | Acquisition of assets from Beep Insights |
| 10 Apr 2026 | 09:12:13 | Share Buyback |
| 8 Apr 2026 | 14:33:09 | Share Buyback |
| 6 Jun 2025 | Annual Report and Accounts (to 2024-12-31) | |
| 4 Jun 2024 | Annual Report and Accounts (to 2023-12-31) | |
| 15 Jun 2023 | Annual Report and Accounts (to 2022-12-31) |
EKF is a prominent manufacturer of point-of-care diagnostics and central laboratory assays, with a global presence in over 100 countries. Their range of products includes hemoglobin, hematocrit, HbA1c, glucose, and lactate analyzers, with an estimated 80,000 units in use worldwide.
Lord Howard of Rising has interests in this issuer
| 27 Apr 2026 | 07:00:10 | Board Changes |
| 24 Apr 2026 | 16:43:41 | Posting of Annual Report & Notice of AGM |
| 13 Apr 2026 | 07:00:03 | Acquisition of assets from Beep Insights |
| 10 Apr 2026 | 09:12:13 | Share Buyback |
| 8 Apr 2026 | 14:33:09 | Share Buyback |
| 6 Jun 2025 | Annual Report and Accounts (to 2024-12-31) | |
| 4 Jun 2024 | Annual Report and Accounts (to 2023-12-31) | |
| 15 Jun 2023 | Annual Report and Accounts (to 2022-12-31) |
EKF is a prominent manufacturer of point-of-care diagnostics and central laboratory assays, with a global presence in over 100 countries. Their range of products includes hemoglobin, hematocrit, HbA1c, glucose, and lactate analyzers, with an estimated 80,000 units in use worldwide.
Lord Howard of Rising has interests in this issuer